Both groups demonstrated a positive trend in the ApoB100/ApoA ratio (with a decrease of 33–60%) and a reduction in the atherogenic index (38% and 53%, respectively).
1
—
—
Both groups demonstrated a positive trend in the ApoB100/ApoA ratio (with a decrease of 33–60%) and a reduction in the atherogenic index (38% and 53%, respectively).